78 reports

Kidney Cancer Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class, By Pharmacologic Class, By Country And Segment Forecasts, 2016 - 2022 Chapter ## Research Methodology ##. ##.

  • Cancer
  • Renal Cancer
  • United States
  • Forecast

REST OF THE WORLD KIDNEY CANCER DRUG MARKET 2014-2022 ($MILLION) LIST OF FIGURES ##.

  • Cancer
  • Pathology
  • Renal Cancer
  • Therapy
  • World
  • Top 20 Countries with Highest Incidence of Kidney Cancer in 2012; Both Sexes
  • Top 20 Countries with Highest Incidence of Kidney Cancer in 2012; Men

Kidney cancer is the twelfth most common cancer diagnosed in the world.

  • Renal Cancer
  • Argos Therapeutics, Inc.
  • AstraZeneca PLC
  • AVEO Oncology
  • Bristol-Myers Squibb Company
  • Global Kidney Cancer Drugs Market
  • Global Kidney Cancer Drugs Market

The disease accounts for less than ##% of all kidney cancer cases.

  • Renal Cancer
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • CHAPTER III KIDNEY CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • Market Size

Chart ##: China' s Kidney Cancer Treatment Drugs Sales Volume (Million Yuan) INTRODUCTION Chapter I Kidney Cancer Treatment Drugs Industry Structure CHAPTER III KIDNEY CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS Kidney cancer is usually define

  • Renal Cancer
  • China
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group
  • CHAPTER III KIDNEY CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • CHAPTER IV KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

In China, kidney cancer accounts for approximately ##% of all adult cancers.

  • Renal Cancer
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Yantai Ausbio Biotech Co., Ltd
  • Trends in the Five-Year Relative Survival (%) of Kidney Cancers in the 8MM, Both Sexes,
  • presents the temporal trends in the age-adjusted incidence rate of kidney cancers in the

Kidney Cancer.

  • Renal Cancer
  • China
  • Japan
  • United States
  • Forecast
  • TRENDS IN THE FIVE-YEAR RELATIVE SURVIVAL (%) OF KIDNEY CANCERS IN THE 8MM, BOTH SEXES,
  • presents the temporal trends in the age-adjusted incidence rate of kidney cancers in the

KIDNEY CANCER.

  • Renal Cancer
  • Eisai Co., Ltd.
  • Exelixis, Inc.
  • Pfizer Inc.
  • Roche Group
  • The following is the list of drugs in phase 2 or phase 3 development for renal cancer-related indications.
  • Forecast

However, although KIM-## has diagnostic sensitivity for kidney cancer, it is well known to reflect many types of kidney injuries, thus limiting its specificity as a diagnostic marker for renal cancer.

  • Renal Cancer
  • World
  • Exelixis, Inc.
  • Merck & Co., Inc.
  • Rexahn Pharmaceuticals, Inc.
  • B) KIDNEY CANCER
  • 2.5.2 KIDNEY CANCER

There is currently only one recently approved mAb PD-## inhibitor, Opdivo (approved in 2015) which is used to treat metastatic kidney cancer (FDA, 2014a; FDA, 2014b).

  • Renal Cancer
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Johnson & Johnson
  • Pfizer Inc.

Until 1980’s, the treatment of kidney cancer included surgical removal of the kidneys.

  • Renal Cancer
  • Therapy
  • United States
  • World
  • Market Size
  • CHAPTER IV KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
  • Chapter IV

Shenzhen Kangtai Biological Products Co., Ltd. is one of the biggest cancer vaccines producers in China.

  • Renal Cancer
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd

Around ##% of all malignant kidney tumors are RCC, with other types including transitional cell carcinoma of the renal pelvis and Wilms’ tumor (nephroblastoma).

  • Cancer
  • Renal Cancer
  • European Union
  • Japan
  • United States

Renal Cancer Treatment: Industry Analysis, R& D Trends and World Market Forecasts 2015-2025 Table of Contents ##.

  • Cancer
  • Renal Cancer
  • Therapy
  • World
  • Market Size

Renal cell cancer

4385 5000 3900
  • RCC IS THE MOST COMMON TYPE OF KIDNEY CANCER
  • EXTRACTING INCIDENCE RATE DATA FOR JAPAN, FRANCE, SPAIN, AND THE UK

Kidney cancer was defined by the IARC as cases with the topographical codes C## (kidney cancer, not of renal pelvis), C## (kidney cancer of renal pelvis), C## (kidney cancer of the ureter), and C## (kidney

  • Renal Cancer
  • European Union
  • Japan
  • North America
  • United States
  • 25 May 2012

RCC is the most common type of kidney cancer.

  • Renal Cancer
  • United States
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H## 2018 Table of Contents ## Introduction ## Kidney Cancer (Renal Cell Cancer) - Overview ## Kidney Cancer (Renal Cell Cancer) - Therapeutics Development ##

  • Cancer
  • Pathology
  • Renal Cancer

Kidney cancer also called renal cancer is a disease in which kidney cells become malignant (cancerous) and grows out of control, forming a tumor.

  • Cancer
  • Pathology
  • Renal Cancer
  • Therapy
  • Product Initiative
  • Jul 10, 2017: Kidney Cancer UK delighted NICE recommends cabozantinib on NHS for kidney cancer patients
  • Jun 12, 2017: Scotland first in UK to make Cabometyx (cabozantinib) routinely available for individuals living with advanced kidney cancer

" We believe it brings us one step closer to fighting kidney cancer, which is rapidly on the rise in the UK.

  • Hepatitis
  • Renal Cancer
  • United States
  • Company
  • Exelixis, Inc.
  • Dec 20, 2017: New class of anti-cancer drug effective against kidney cancer

" One of the biggest challenges we face across all treatments for kidney cancer is pairing the right drug with the right patient, " said Dr.

  • Renal Cancer
  • Therapy
  • United States
  • Company
  • Peloton Therapeutics, Inc.
  • AUG 23, 2018: HEIDELBERG PHARMA: PARTNER TELIX PHARMACEUTICALS FILES PHASE III TRIAL FOR KIDNEY CANCER IMAGING IN EUROPE
  • FEATURED NEWS & PRESS RELEASES

All C##(##)/ SV## T-Ag mice in the control and paclitaxel treated groups developed palpable mammary cancer.

  • Brain Cancer
  • Renal Cancer
  • United States
  • World
  • Product Initiative
  • IROFULVEN IN TREATING PATIENTS WITH METASTATIC KIDNEY CANCER
  • A TRIAL LOOKING AT RAD001, INTERFERON AND BEVACIZUMAB FOR KIDNEY CANCER THAT HAS SPREAD

FINDINGS FROM AN EXPLORATORY ENDPOINT SHOWED PATIENTS REPORTED STATISTICALLY SIGNIFICANTLY BETTER KIDNEY CANCER SYMPTOM CONTROL WITH THE OPDIVO PLUS YERVOY COMBINATION COMPARED TO SUNITINIB, WHEN ASSESSED USING A VALID TUMOR-SPECIFIC PATIENT-REPORTED KIDNEY

  • Clinical Trial
  • Hospital
  • Monoclonal Antibody
  • Renal Cancer
  • Pfizer Inc.

## Antibody In Murine Models Of Colorectal Cancer ## Jun ##, 2018: Surface Oncology Announces Initiation of Phase I Clinical Trial of SRF## / NZV## ## Jun ##, 2018: Arcus Biosciences Announces FDA Clearance of INDs for AB## and AB## and Initiation of Phase ##/ ##

  • Cancer
  • Clinical Trial
  • Drug Development
  • Renal Cancer
  • World
  • NOV 21, 2011: MOLOGEN ATTAINS GOALS OF RENAL CANCER STUDY WITH MGN1601 AHEAD OF SCHEDULE
  • FEB 03, 2014: MOLOGEN: FINAL RESULTS FROM RENAL CANCER TRIAL WITH MGN1601 PRESENTED AT ASCO GENITOURINARY CANCERS SYMPOSIUM

In the case of one patient, the size of the metastases was reduced by more than ##%, and in two cases, progress of the renal cancer was stopped.

  • Cancer
  • Renal Cancer
  • World
  • Product Initiative
  • MOLOGEN AG

Pazopanib is a new targeted cancer medicine used for treatment of advanced kidney cancer patients.

  • Cancer
  • Immunotherapy
  • Renal Cancer
  • Therapy
  • Novartis AG
  • during the first six months of treatment. The results were published in New England Journal of Medicine.

Two oral targeted drugs approved for metastatic kidney cancer worked equally well, but one proved superior in tolerability, according to results of a large international clinical trial led by researchers at Dana-Farber Cancer Institute.

  • Cancer
  • Immunotherapy
  • Renal Cancer
  • Therapy
  • Novartis AG
  • KIDNEY CANCER (1/2)
  • KIDNEY CANCER (2/2)

In 2014, in developing countries, ##% of total kidney cancer cases reported among men and ##% of total kidney cancer cases reported among women were caused due to smoking (Source: Cancer.

  • Renal Cancer
  • North America
  • United States
  • World
  • SonaCare Medical, LLC
  • NOV 05, 2015: REXAHN PHARMACEUTICALS REPORTS INTERIM CLINICAL DATA FOR ARCHEXIN AT THE 14TH INTERNATIONAL KIDNEY CANCER SYMPOSIUM
  • JAN 11, 2016: REXAHN PHARMACEUTICALS ARCHEXIN SHOWS DOSE-DEPENDENT TUMOR REDUCTION IN A PHASE IIA CLINICAL STUDY

The presentation is entitled as Archexin, A New AKT-## Specific Inhibitor for the Treatment of Metastatic Renal Cancer".

  • Renal Cancer
  • Targeted Therapy
  • Therapy
  • United States
  • Product Initiative
  • High-Grade Glioma
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018 (CONTD..5), H1 2018

LENVIMA is also indicated to treat adults with a form of advanced kidney cancer.

  • Renal Cancer
  • United States
  • World
  • Product Initiative
  • Eisai Co., Ltd.
  • JUN 12, 2017: SCOTLAND FIRST IN UK TO MAKE CABOMETYX (CABOZANTINIB) ROUTINELY AVAILABLE FOR INDIVIDUALS LIVING WITH ADVANCED KIDNEY CANCER
  • JUN 12, 2017: EXELIXIS ANNOUNCES INITIATION OF PHASE 1B TRIAL OF CABOZANTINIB IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMORS

" The positive recommendation by the SMC is very welcome news for advanced kidney cancer patients in Scotland" commented Karen McNee, Kidney Cancer Scotland.

  • Oncology
  • Renal Cancer
  • World
  • Product Initiative
  • Exelixis, Inc.